United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares

United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the business's stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $569.28, for a total transaction of $5,408,160.00. Following the completion of the transaction, the chief executive officer directly owned 40,513 shares